Craft

Shandong Wohua Pharmaceutical

Stock Price

¥4.9

2024-10-29

Market Capitalization

¥2.8 B

2024-10-29

Revenue

¥797.7 M

FY, 2025

Shandong Wohua Pharmaceutical Summary

Company Summary

Overview
Shandong Wohua Pharmaceutical (also known as 山东沃华医药科技股份有限公司) is a company that manufactures and markets pharmaceutical products. It offers xinkeshu tablets, naoxueshu oral solutions, tongluo huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; and other products.
Type
Public
Status
Active
Founded
2002
Website
https://www.wohua.cn
Cybersecurity rating
Sectors

Table of Contents

Shandong Wohua Pharmaceutical Financials

Summary Financials

Revenue (Q1, 2026)
¥215.2M
Gross profit (Q1, 2026)
¥167.0M
Net income (Q1, 2026)
¥38.5M
Cash (Q1, 2026)
¥373.4M
EBIT (Q1, 2026)
¥43.7M
Enterprise value
$2.4B

Footer menu